{"transactions":[{"id":4261750,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":174555,"kind":"organization","name":"EXCEL MEDICAL FUND LP","position":1,"cik":"0001428044","reported_name":"EXCEL MEDICAL FUND LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90806,"kind":"person","name":"Gullans Steven R. Ph.D.","position":2,"cik":"0001571997","reported_name":"Gullans Steven R. Ph.D.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":174556,"kind":"person","name":"Blume Frederick R.","position":3,"cik":"0001572066","reported_name":"Blume Frederick R.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":174557,"kind":"person","name":"Enriquez Juan","position":4,"cik":"0001572090","reported_name":"Enriquez Juan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":174558,"kind":"organization","name":"Excel Medical Ventures, LLC","position":5,"cik":"0001571999","reported_name":"Excel Medical Ventures, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series F Preferred Stock","published_at":"2017-07-06T18:16:08.000Z","date":"2017-07-05","kind":"exercise","acquired":false,"shares":1083119,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series D, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series D, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series D, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Excel Medical Ventures, LLC is the general partner of Excel Medical Fund, L.P. Steven R. Gullans, Frederick R. Blume and Juan Enriquez are the Managing Directors of Excel Medical Ventures, LLC. Excel Medical\nVentures, LLC and each of these individuals may be deemed to share voting and dispositive power with respect to all shares held by Excel Medical Fund, L.P. Each of the filing persons disclaims beneficial ownership of\nthe shares except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":108998},"source":{"system":"sec-edgar","filing":"0000899243-17-018010","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1428044/000089924317018010/doc4.xml","form_type":"4"}},{"id":4261749,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":174555,"kind":"organization","name":"EXCEL MEDICAL FUND LP","position":1,"cik":"0001428044","reported_name":"EXCEL MEDICAL FUND LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90806,"kind":"person","name":"Gullans Steven R. Ph.D.","position":2,"cik":"0001571997","reported_name":"Gullans Steven R. Ph.D.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":174556,"kind":"person","name":"Blume Frederick R.","position":3,"cik":"0001572066","reported_name":"Blume Frederick R.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":174557,"kind":"person","name":"Enriquez Juan","position":4,"cik":"0001572090","reported_name":"Enriquez Juan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":174558,"kind":"organization","name":"Excel Medical Ventures, LLC","position":5,"cik":"0001571999","reported_name":"Excel Medical Ventures, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series E-3 Preferred Stock","published_at":"2017-07-06T18:16:08.000Z","date":"2017-07-05","kind":"exercise","acquired":false,"shares":1153606,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series D, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series D, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series D, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Excel Medical Ventures, LLC is the general partner of Excel Medical Fund, L.P. Steven R. Gullans, Frederick R. Blume and Juan Enriquez are the Managing Directors of Excel Medical Ventures, LLC. Excel Medical\nVentures, LLC and each of these individuals may be deemed to share voting and dispositive power with respect to all shares held by Excel Medical Fund, L.P. Each of the filing persons disclaims beneficial ownership of\nthe shares except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":116091},"source":{"system":"sec-edgar","filing":"0000899243-17-018010","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1428044/000089924317018010/doc4.xml","form_type":"4"}},{"id":4261748,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":174555,"kind":"organization","name":"EXCEL MEDICAL FUND LP","position":1,"cik":"0001428044","reported_name":"EXCEL MEDICAL FUND LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90806,"kind":"person","name":"Gullans Steven R. Ph.D.","position":2,"cik":"0001571997","reported_name":"Gullans Steven R. Ph.D.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":174556,"kind":"person","name":"Blume Frederick R.","position":3,"cik":"0001572066","reported_name":"Blume Frederick R.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":174557,"kind":"person","name":"Enriquez Juan","position":4,"cik":"0001572090","reported_name":"Enriquez Juan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":174558,"kind":"organization","name":"Excel Medical Ventures, LLC","position":5,"cik":"0001571999","reported_name":"Excel Medical Ventures, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series E-2 Preferred Stock","published_at":"2017-07-06T18:16:08.000Z","date":"2017-07-05","kind":"exercise","acquired":false,"shares":1329993,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series D, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series D, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series D, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Excel Medical Ventures, LLC is the general partner of Excel Medical Fund, L.P. Steven R. Gullans, Frederick R. Blume and Juan Enriquez are the Managing Directors of Excel Medical Ventures, LLC. Excel Medical\nVentures, LLC and each of these individuals may be deemed to share voting and dispositive power with respect to all shares held by Excel Medical Fund, L.P. Each of the filing persons disclaims beneficial ownership of\nthe shares except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":133842},"source":{"system":"sec-edgar","filing":"0000899243-17-018010","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1428044/000089924317018010/doc4.xml","form_type":"4"}},{"id":4261747,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":174555,"kind":"organization","name":"EXCEL MEDICAL FUND LP","position":1,"cik":"0001428044","reported_name":"EXCEL MEDICAL FUND LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90806,"kind":"person","name":"Gullans Steven R. Ph.D.","position":2,"cik":"0001571997","reported_name":"Gullans Steven R. Ph.D.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":174556,"kind":"person","name":"Blume Frederick R.","position":3,"cik":"0001572066","reported_name":"Blume Frederick R.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":174557,"kind":"person","name":"Enriquez Juan","position":4,"cik":"0001572090","reported_name":"Enriquez Juan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":174558,"kind":"organization","name":"Excel Medical Ventures, LLC","position":5,"cik":"0001571999","reported_name":"Excel Medical Ventures, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Preferred Stock","published_at":"2017-07-06T18:16:08.000Z","date":"2017-07-05","kind":"exercise","acquired":false,"shares":5934050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series D, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series D, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series D, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Excel Medical Ventures, LLC is the general partner of Excel Medical Fund, L.P. Steven R. Gullans, Frederick R. Blume and Juan Enriquez are the Managing Directors of Excel Medical Ventures, LLC. Excel Medical\nVentures, LLC and each of these individuals may be deemed to share voting and dispositive power with respect to all shares held by Excel Medical Fund, L.P. Each of the filing persons disclaims beneficial ownership of\nthe shares except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":597167},"source":{"system":"sec-edgar","filing":"0000899243-17-018010","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1428044/000089924317018010/doc4.xml","form_type":"4"}},{"id":4261746,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":174555,"kind":"organization","name":"EXCEL MEDICAL FUND LP","position":1,"cik":"0001428044","reported_name":"EXCEL MEDICAL FUND LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90806,"kind":"person","name":"Gullans Steven R. Ph.D.","position":2,"cik":"0001571997","reported_name":"Gullans Steven R. Ph.D.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":174556,"kind":"person","name":"Blume Frederick R.","position":3,"cik":"0001572066","reported_name":"Blume Frederick R.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":174557,"kind":"person","name":"Enriquez Juan","position":4,"cik":"0001572090","reported_name":"Enriquez Juan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":174558,"kind":"organization","name":"Excel Medical Ventures, LLC","position":5,"cik":"0001571999","reported_name":"Excel Medical Ventures, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-07-06T18:16:08.000Z","date":"2017-07-05","kind":"purchase","acquired":true,"shares":60000,"price":15,"value":900000.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Excel Medical Ventures, LLC is the general partner of Excel Medical Fund, L.P. Steven R. Gullans, Frederick R. Blume and Juan Enriquez are the Managing Directors of Excel Medical Ventures, LLC. Excel Medical\nVentures, LLC and each of these individuals may be deemed to share voting and dispositive power with respect to all shares held by Excel Medical Fund, L.P. Each of the filing persons disclaims beneficial ownership of\nthe shares except to the extent of any pecuniary interest therein."}],"balance_after":1016100,"source":{"system":"sec-edgar","filing":"0000899243-17-018010","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1428044/000089924317018010/doc4.xml","form_type":"4"}},{"id":4261745,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":174555,"kind":"organization","name":"EXCEL MEDICAL FUND LP","position":1,"cik":"0001428044","reported_name":"EXCEL MEDICAL FUND LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90806,"kind":"person","name":"Gullans Steven R. Ph.D.","position":2,"cik":"0001571997","reported_name":"Gullans Steven R. Ph.D.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":174556,"kind":"person","name":"Blume Frederick R.","position":3,"cik":"0001572066","reported_name":"Blume Frederick R.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":174557,"kind":"person","name":"Enriquez Juan","position":4,"cik":"0001572090","reported_name":"Enriquez Juan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":174558,"kind":"organization","name":"Excel Medical Ventures, LLC","position":5,"cik":"0001571999","reported_name":"Excel Medical Ventures, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-07-06T18:16:08.000Z","date":"2017-07-05","kind":"exercise","acquired":true,"shares":956100,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series D, Series E-2, Series E-3 and Series F Preferred Stock converted into Common Stock on a 9.937-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D, Series E-2, Series E-3 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Excel Medical Ventures, LLC is the general partner of Excel Medical Fund, L.P. Steven R. Gullans, Frederick R. Blume and Juan Enriquez are the Managing Directors of Excel Medical Ventures, LLC. Excel Medical\nVentures, LLC and each of these individuals may be deemed to share voting and dispositive power with respect to all shares held by Excel Medical Fund, L.P. Each of the filing persons disclaims beneficial ownership of\nthe shares except to the extent of any pecuniary interest therein."}],"balance_after":956100,"source":{"system":"sec-edgar","filing":"0000899243-17-018010","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1428044/000089924317018010/doc4.xml","form_type":"4"}}]}